| Dr Susan Perlmutter, MD | |
|
106 Elden St Ste 17, Herndon, VA 20170-4840 | |
| (703) 481-5214 | |
| Not Available |
| Full Name | Dr Susan Perlmutter |
|---|---|
| Gender | Female |
| Speciality | Psychiatry & Neurology - Child & Adolescent Psychiatry |
| Location | 106 Elden St Ste 17, Herndon, Virginia |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1134252380 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0804X | Psychiatry & Neurology - Child & Adolescent Psychiatry | 0101056954 (Virginia) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Susan Perlmutter, MD 106 Elden St Ste 17, Herndon, VA 20170-4840 Ph: (703) 481-5214 | Dr Susan Perlmutter, MD 106 Elden St Ste 17, Herndon, VA 20170-4840 Ph: (703) 481-5214 |
News Archive
SAGE Therapeutics, a biopharmaceutical company developing novel medicines to treat specialty, critical and orphan central nervous system (CNS) disorders, today announced the successful completion of a $38 million Series C financing. OrbiMed Advisors, LLC, EcoR1 Capital Management, Foresite Capital Management and two undisclosed blue chip public investment funds joined existing investors Third Rock Ventures and ARCH Venture Partners.
Some cancers can be effectively treated with drugs inhibiting proteins known as receptor tyrosine kinases, but not those cancers caused by mutations in the KRAS gene. A team of researchers led by Jeffrey Engelman, at Massachusetts General Hospital Cancer Center, Boston, has now identified a potential way to effectively use receptor tyrosine kinases inhibitors to treat individuals with KRAS mutant colorectal cancers - combine them with inhibitors of the MEK/ERK signaling pathway.
In a recent article publicly available at medRxiv, researchers from Stanford have presented a single-cell atlas of the peripheral immune response to coronavirus disease (COVID-19), highlighting pertinent immunological features associated with the severe forms of the disease.
When a receptor on the surface of a T cell - a sentry of the human immune system - senses a single particle from a harmful intruder, it immediately kicks the cell into action, launching a larger immune response. But exactly how the signal from a single receptor, among thousands on each T cell, can be amplified to affect a whole cell has puzzled immunologists for decades.
› Verified 4 days ago
Dr. Rhea Nishita Mehra, M.D Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 489 Carlisle Dr Ste A, Herndon, VA 20170 Phone: 703-774-3234 Fax: 703-880-8414 | |
Churchill G Dunn Ii, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 131 Elden St #150, Herndon, VA 20170 Phone: 703-402-4941 Fax: 703-430-9293 | |
Gaurav Jain, DO Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 13028 Monroe Manor Dr, Herndon, VA 20171 Phone: 703-899-5644 | |
Dr. Stephanie Ellen Waggel, MD, MS Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 2201 Cooperative Way Ste 600, Herndon, VA 20171 Phone: 646-776-0739 Fax: 703-788-6867 | |
Dr. Caroline M. Tan, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 297 Herndon Pkwy, Suite 202, Herndon, VA 20170 Phone: 571-323-3300 Fax: 571-323-3300 | |
Dr. Eric Robert Anderson, M.D., PH.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 2411 Dulles Corner Park Ste 475, Herndon, VA 20171 Phone: 800-762-9244 Fax: 786-672-6006 |